MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
IMTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Immatics (IMTX) Ownership - Who owns Immatics?

Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
Paul-Ehrlich-Strasse 15
Phone
+49 707153970
Employees
711
Web
https://www.immatics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.25B
P/E Ratio
27.61
Total Cash
453.57M
Projected Growth
N/A
Total Debt
15.08M
Revenue
37.3M
Risk (Beta)
1.67
Dividend Yield
N/A
Total Cash/Share
3.32
Total Debt/Equity
N/A
Revenue/Share
0.34 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
IMTX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for IMTX
A.I. Advisor
published General Information

General Information

a clinical stage biopharmaceutical company, which engages in the research and development of T cell receptor-based immunotherapies for the treatment of cancer

Industry Biotechnology

Profile
Details
Industry
N/A
Address
Paul-Ehrlich-Strasse 15
Phone
+49 707153970
Employees
711
Web
https://www.immatics.com